Active substance
Lactulose
- SFDA 15
- US FDA 38
- Health Canada 5
- US price lines 12
- NHS prices 2
- WHO EML 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| DUPHALAC ORAL SOLUTION | 667 g/l | Oral solution · Oral use | 1 Bottle | SAR 24.40 | NCE · OTC | ABBOTT BIOLOGICALS | Valid |
| EZILAX 10G-15ML SYRUP | 0.67 g/ml | Syrup · Oral use | 1 Bottle | SAR 21.95 | Generic · OTC | Tabuk Pharmaceutical Manufacturing Company | Valid |
| KULAX 65MG-100ML SYRUP | 0.65 mg/ml | Syrup · Oral use | 1 Bottle | SAR 15.25 | Generic · OTC | KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES | Valid |
| KULAX 65MG-100ML SYRUP | 0.65 mg/ml | Syrup · Oral use | 1 Bottle | SAR 10.15 | Generic · OTC | KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES | Valid |
| LACTULOSE syrup | 0.65 g/ml | Syrup · Oral use | 1 Bottle | SAR 17.00 | Generic · OTC | EIPICO | Valid |
| LAXILOSE SYRUP | 67 % | Syrup · Oral use | 1 Bottle | SAR 18.45 | Generic · OTC | SAUDI PHARMACEUTICAL INDUSTRIES | Valid |
| LAXOLAC SYRUP | 0.65 g/ml | Syrup · Oral use | 1 Bottle | SAR 7.00 | Generic · OTC | MEDICAL UNION PHARMACEUTICALS CO | Valid |
| LAXOLAC SYRUP | 0.65 g/ml | Syrup · Oral use | 1 Bottle | SAR 15.25 | Generic · OTC | MEDICAL UNION PHARMACEUTICALS CO | Valid |
| SOFLAX SOLUTION | 0.67 g/ml | Solution · Oral use | 1 Bottle | SAR 9.95 | Generic · OTC | Gulf Pharmaceutical Industries (Julphar) | Valid |
| DEFOLAX 65GM-100ML SYRUP | 0.65 g/ml | Syrup · Oral use | 1 Bottle | SAR 11.20 | Generic · OTC | DEEF PHARMACEUTICAL INDUSTRIES | Withdrawn by MAH · Not Marketed |
| EZILAX 10GM POWDER SACHET | 10 g | Powder for oral solution · Oral use | 20 Sachet | SAR 16.80 | NCE · OTC | Tabuk Pharmaceutical Manufacturing Company | Withdrawn by MAH · Not Marketed |
| RAMLAC 67GM-100ML SYRUP | 0.67 g/ml | Syrup · Oral use | 1 Bottle | SAR 13.75 | Generic · OTC | Ram Pharmaceutical Industries | Withdrawn by MAH · Not Marketed |
| RIALAC LIQUID | 0.67 g/ml | Oral solution · Oral use | 1 Bottle | SAR 11.10 | Generic · OTC | RIYADH PHARMA | Withdrawn by MAH · Not Marketed |
| RIALAC LIQUID | 0.67 g/ml | Oral solution · Oral use | 1 Bottle | SAR 15.55 | Generic · OTC | RIYADH PHARMA | Withdrawn by MAH · Not Marketed |
| SEDALAC SYRUP 3.35G-5ML | 0.65 g/ml | Oral solution · Oral use | 1 Bottle | SAR 6.30 | Generic · OTC | SEDICO | Withdrawn by regulatory authority · Not Marketed |
Indications — CHI Daman Drug Formulary
ACUTE LIVER FAILURE - HEPATIC ENCEPHALOPATHY/HYPERAMMONEMIA; ANAL FISSURE; CONSTIPATION; HEMORRHOIDS; IRRITABLE BOWEL SYNDROME; LIVER CIRRHOSIS
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| LACTULOSE | 10GM/15ML | solution · oral | PHARM ASSOC | Prescription | 30 Jul 1996 |
| GENERLAC | 10GM/15ML | solution · oral, rectal | CHARTWELL RX | Prescription | 31 Oct 1996 |
| LACTULOSE | 10GM/15ML | solution · oral | AUROBINDO PHARMA LTD | Prescription | 14 Nov 1996 |
| LACTULOSE | 10GM/PACKET; 20GM/PACKET | for solution · oral | APOTEX | Prescription | 10 Dec 1997 |
| LACTULOSE | 10GM/15ML | solution · oral | LANNETT CO INC | Prescription | 26 Jul 2001 |
| LACTULOSE | 10GM/15ML | solution · oral | PHARMOBEDIENT | Prescription | 21 Feb 2002 |
| LACTULOSE | 10GM/15ML | solution · oral, rectal | BAJAJ | Prescription | 28 Jul 2003 |
| LACTULOSE | 10GM/15ML | solution · oral, rectal | FRESENIUS KABI | Prescription | 25 Jan 2012 |
| LACTULOSE | 10GM/15ML | solution · oral | FRESENIUS KABI | Prescription | 25 Jan 2012 |
| LACTULOSE | 10GM/15ML | solution · oral, rectal | APOZEAL PHARMS | Prescription | 27 Mar 2015 |
| LACTULOSE | 10GM/15ML | solution · oral | APOZEAL PHARMS | Prescription | 11 Jun 2018 |
| LACTULOSE | 10GM/15ML | solution · oral | CHARTWELL RX | Prescription | 23 Nov 2018 |
| LACTULOSE | 10GM/15ML | solution · oral | TARO | Prescription | 13 Dec 2024 |
| LACTULOSE | 10GM/PACKET; 20GM/PACKET | for solution · oral | PAI HOLDINGS | Prescription | 14 Mar 2025 |
| CEPHULAC | 10GM/15ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | solution · oral, rectal | SANOFI AVENTIS US | Discontinued | 25 Mar 1976 |
| CHRONULAC | 10GM/15ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | solution · oral | SANOFI AVENTIS US | Discontinued | 20 Jun 1979 |
| CONSTILAC | 10GM/15ML | solution · oral | ALRA | Discontinued | 26 Jul 1988 |
| CHOLAC | 10GM/15ML | solution · oral, rectal | ALRA | Discontinued | 26 Jul 1988 |
| CONSTULOSE | 10GM/15ML | solution · oral | ACTAVIS MID ATLANTIC | Discontinued | 15 Aug 1988 |
| ENULOSE | 10GM/15ML | solution · oral, rectal | ACTAVIS MID ATLANTIC | Discontinued | 15 Aug 1988 |
| LACTULOSE | 10GM/15ML | solution · oral, rectal | ROXANE | Discontinued | 29 May 1992 |
| LACTULOSE | 10GM/15ML | solution · oral | HIKMA PHARMS | Discontinued | 29 May 1992 |
| LACTULOSE | 10GM/15ML | solution · oral | VISTAPHARM LLC | Discontinued | 30 Sep 1992 |
| EVALOSE | 10GM/15ML | solution · oral | TEVA PHARMS | Discontinued | 28 May 1993 |
| HEPTALAC | 10GM/15ML | solution · oral, rectal | TEVA PHARMS | Discontinued | 28 May 1993 |
13 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| JAMP-LACTULOSE | 02295881 | 667 MG / ML | SOLUTION · ORAL | JAMP PHARMA CORPORATION |
| LACTULOSE | 02412268 | 667 MG / ML | SOLUTION · ORAL | SANIS HEALTH INC |
| PMS-LACTULOSE-PHARMA | 02469391 | 667 MG / ML | SOLUTION · ORAL | PHARMASCIENCE INC |
| RATIO-LACTULOSE | 00854409 | 667 MG / ML | SOLUTION · ORAL | TEVA CANADA LIMITED |
| TEVA-LACTULOSE | 02331551 | 667 MG / ML | SOLUTION · ORAL | TEVA CANADA LIMITED |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | CONSTULOSE 10 GM/15 ML SOLN | $0.01947 | per ML | 23 Sep 2026 |
| US NADAC | CONSTULOSE 10 GM/15 ML SOLN | $0.01939 | per ML | 23 Sep 2026 |
| US NADAC | ENULOSE 10 GM/15 ML SOLUTION | $0.01304 | per ML | 23 Sep 2026 |
| US NADAC | GENERLAC 10 GM/15 ML SOLUTION | $0.01304 | per ML | 23 Sep 2026 |
| US NADAC | LACTULOSE 10 GM PACKET | $8.22014 | per EA | 23 Sep 2026 |
| US NADAC | LACTULOSE 10 GM/15 ML SOLUTION | $0.01947 | per ML | 23 Sep 2026 |
| US NADAC | LACTULOSE 10 GM/15 ML SOLUTION | $0.02237 | per ML | 23 Sep 2026 |
| US NADAC | LACTULOSE 10 GM/15 ML SOLUTION | $0.01939 | per ML | 23 Sep 2026 |
| US NADAC | LACTULOSE 10 GM/15 ML SOLUTION | $0.01304 | per ML | 23 Sep 2026 |
| US NADAC | LACTULOSE 10 GM/15 ML SOLUTION | $0.0125 | per ML | 23 Sep 2026 |
| US NADAC | LACTULOSE 20 GM PACKET | $8.51402 | per EA | 23 Sep 2026 |
| US NADAC | LACTULOSE 20 GM/30 ML SOLUTION CUP | $0.0512 | per ML | 18 Feb 2026 |
| NHS Drug Tariff | Lactulose 10g/15ml oral solution 15ml sachets sugar free | £3.52 | 10 sachet | 1 Oct 2026 |
| NHS Drug Tariff | Lactulose 3.1-3.7g/5ml oral solution | £3.63 | 500 ml | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 2.3. Medicines for other common symptoms in palliative care · core
Palliative care
Oral > Liquid: 3.3 to 3.4 g per 5 mL oral liquid (EMLc)
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.